Table 7 Reported sinus pathology
From: Long-term treatment outcomes with zygomatic implants: a systematic review and meta-analysis
Study | Mean follow-up | % of patients experiencing sinusitis during follow-up | Individual patient level timeframe data | Presence of oro-antral communication/fistula during follow-up | Intra or extra-sinus zygomatic implant path | Zygomatic implant loss related to sinusitis | Management | Previous history of sinusitis |
|---|---|---|---|---|---|---|---|---|
Kahnberg et al. 2007 | 36 | 18.4% (n = 14) | Not reported | 3.9% (n = 3) | Path involving the sinus | Not reported | Not reported | Not reported |
Aparicio et al. 2014 | 55.24 | 3.7% (n = 3) | Not reported | 2.5% (n = 2) | Path involving the sinus | Not reported | Not reported | Not reported |
Malo et al. 2014 | 60 | 13% (n = 5) | Sinusitis diagnosed in 2 patients at 2 months then individual patients at 6, 12 and 24 months, respectively | 1.08% (n = 1) | Extra-maxillary approach | 1.08% (n = 1) in 2.6% (n = 1) patient | Antibiotics for 2 patients and surgical management for 2 successful for 4 of 5 patients | 13% (n = 5) patients |
Davo, Malevez and Pons 2013 | 60 | 1.7% (n = 1) | Not reported | Sinusitis (n = 1) Pain and swelling at zygomatic level (n = 1) | Intra and extra-maxillary paths | Not reported | Antibiotics and meatotomy successful | Not reported |
Davo 2009 | 60 | 23.8% (n = 5) | Not reported | Not reported | Path involving the sinus | No failures due to sinusitis | 2 patients Antibiotics, 2 patients meatotomy or 1 patient Caldwell Luc. All successful treatments | Not reported |
Branemark et al. 2004 | 60 | 14.2% (n = 4) | Not reported | Not reported | Path involving the sinus | Not reported | Meatotomy on 4 patients | 3.5% (n = 1) patient |
Davo and Pons 2015 | 60 | 14% (n = 2) | Sinus infection diagnosed at 24 and 30 months, respectively | Fistula at 1 implant | Path involving the sinus | Not reported | Antimicrobial therapy successful in managing disease | Not reported |
Chana et al. 2019 | 90 | 6.6% (n = 3) | Not reported | Not reported | Intra and extra-maxillary paths | 3.4% (n = 3) in 6.6% (n = 3) patients | Not reported | Not reported |
Agliardi et al. 2017 | 85.04 | 6.7% (n = 1) | 5 months after placement | 6.7% (n = 1) | Path involving the sinus | 0% (n = 0) | Antimicrobial therapy successful in managing disease | Not reported |
Aparicio et al. 2014 | 120 | 27.3% (n = 6) | Post placement, 1–2 years, 2–3 years, 7–8, 8–9, 10–11 | 3.75% (n = 80) | Path involving the sinus | 1.5% (n = 2) in 4.5% (n = 1) patient | 5 patients successfully managed with antimicrobials | Not reported |
Cosola et al. 2021 | 141.6 | 32.8% (n = 12) | Not reported | Not reported | 70.2% (n = 47) completely intrasinusal. 29.85% (n = 20) not completely intrasinusal | 23.9% (n = 16) in 24.24% (n = 8) patients | Not reported | Not reported |